Company intelligence / Profile preview

Heraeus

Hanau, Hesse, Germanyheraeus-group.com ↗

Ownership: Private
Employees: ~17200
Development stage: Commercial

Overview

Heraeus is a global leader in platinum-based highly potent active pharmaceutical ingredients for cancer therapies, with commercial manufacturing capabilities. Its bone cement product PALACOS® is considered the gold standard in joint replacement surgeries with over 40 million documented uses worldwide. The company also provides contract development and manufacturing services to pharma/biotech partners across pre-clinical to commercial stages.

Therapeutic areas: OncologyRheumatology
Modalities: Small moleculeDeviceBiomaterials
Industry: Implantable Medical Devices

Partnerships

Evonik Industries AG

Beyond the preview

Go deeper on Heraeus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heraeus.

Explore the full profile